Atlas Trials

Efficacy of Solifenacin or Mirabegron With Local Estrogen Versus Combination Pharmacotherapy for Overactive Bladder

Clinical trial NCT06479720 · RECRUITING

Trial details

NCT number
NCT06479720
Sponsor
Mackay Memorial Hospital
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Effect of DrugUrinary Bladder, Overactive
Start date
2022-06-16
Primary completion
2026-06-30
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.